Email Alert RSS
Volume 13 Issue 6
Nov.  2022
Turn off MathJax
Article Contents
Abstract
References
Related Articles
Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
Citation: Chinese Urological Doctor Association Adrenal Hypertension Surgery Collaborative Organization Adrenal Group, Chinese Society of Endocrinology PET group, Chinese Society of Nuclear Medicine. Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(6): 986-991. DOI: 10.12290/xhyxzz.2022-0584
shu

Consensus on Clinical Application of the CXCR4-targeted Imaging in the Diagnosis of Primary Aldosteronism(2022)

Funds: 

National High Level Hospital Clinical Research Funding 2022-PUMCH-C-028

National High Level Hospital Clinical Research Funding 2022-PUMCH-B-010

CAMS Innovation Fund for Medical Sciences 2022-I2M-JB-001

More Information
  • Received Date: October 08, 2022
  • Accepted Date: October 24, 2022
  • Available Online: November 06, 2022
  • Issue Publish Date: November 29, 2022
    Graphical Abstract
    • Abstract
  • Subtype classification of primary aldosteronism is important but challenging. Increasing evidence has shown that 68Ga-Pentixafor PET/CT imaging which targets CXCR4 is beneficial to the subtype classification of primary aldosteronism. Based on all the available evidence, and after in-depth discussion of a group of multi-disciplinary experts, a consensus has been established, which covers imaging technology, interpretation of results of CXCR4 imaging, and the guidance to the choice of the treatment and prognosisevaluation. The consensus is helpful for standardizing 68Ga-Pentixafor PET/CT imaging and promoting a better diagnosis procedure in primary aldosteronism.
    • FullText(HTML)
    • References (15)
  • [1]
    Funder JW, Carey RM, Mantero F, et al. The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline[J]. J Clin Endocrinol Metab, 2016, 101: 1889-1916. DOI: 10.1210/jc.2015-4061
    [2]
    Mulatero P, Monticone S, Deinum J, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension[J]. J Hypertens, 2020, 38: 1919-1928. DOI: 10.1097/HJH.0000000000002510
    [3]
    Wang H, Wang F, Zhang Y, et al. Surgical Outcomes of Aldosterone-Producing Adenoma on the Basis of the Histopathological Findings[J]. Front Endocrinol (Lausanne), 2021, 12: 663096. DOI: 10.3389/fendo.2021.663096
    [4]
    Mulatero P, Sechi LA, Williams T A, et al. Subtype diagnosis, treatment, complications and outcomes of primary aldosteronism and future direction of research: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension[J]. J Hypertens, 2020, 38: 1929-1936. DOI: 10.1097/HJH.0000000000002520
    [5]
    Walenkamp A, Lapa C, Herrmann K, et al. CXCR4 Ligands: The Next Big Hit?[J]. J Nucl Med, 2017, 58: 77S-82S. DOI: 10.2967/jnumed.116.186874
    [6]
    Heinze B, Fuss CT, Mulatero P, et al. Targeting CXCR4 (CXC Chemokine Receptor Type 4) for Molecular Imaging of Aldosterone-Producing Adenoma[J]. Hypertension, 2018, 71: 317-325. DOI: 10.1161/HYPERTENSIONAHA.117.09975
    [7]
    Ding J, Zhang Y, Wen J, et al. Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism[J]. Eur J Nucl Med Mol Imaging, 2020, 47: 2656-2665. DOI: 10.1007/s00259-020-04722-0
    [8]
    Ding J, Tong A, Zhang Y, et al. Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using (68)Ga-Pentixafor[J]. J Nucl Med, 2022, 63: 368-375. DOI: 10.2967/jnumed.121.261964
    [9]
    Ding J, Tong A, Zhang Y, et al. Intense 68Ga-Pentixafor Activity in Aldosterone-Producing Adrenal Adenomas[J]. Clin Nucl Med, 2020, 45: 336-339. DOI: 10.1097/RLU.0000000000002946
    [10]
    Gao Y, Ding J, Cui Y, et al. Functional nodules in primary aldosteronism: identification of CXCR4 expression with (68)Ga-Pentixafor PET/CT[J]. Eur Radiol, 2022. doi: 10.1007/s00330-022-09058-x.
    [11]
    Song Y, Yang J, Shen H, et al. Development and validation of model for sparing adrenal venous sampling in diagnosing unilateral primary aldosteronism[J]. J Hypertens, 2022, 40: 1692-1701. DOI: 10.1097/HJH.0000000000003197
    [12]
    Fu B, Zhang X, Wang GX, et al. Long-term results of a prospective, randomized trial comparing retroperitoneoscopic partial versus total adrenalectomy for aldosterone producing adenoma[J]. J Urol, 2011, 185: 1578-1582. DOI: 10.1016/j.juro.2010.12.051
    [13]
    中华医学会内分泌学分会. 原发性醛固酮增多症诊断治疗的专家共识(2020版)[J]. 中华内分泌代谢杂志, 2020, 36: 727-736. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ202111003.htm

    Chinese Society of Endocrinology. Expert consensus on the diagnosis and treatment of primary aldosteronism (2020)[J]. Zhonghua Neifenmi Daixie Zazhi, 2020, 36: 727-736. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGGZ202111003.htm
    [14]
    Steichen O, Zinzindohoué F, Plouin PF, et al. Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review[J]. Horm Metab Res, 2012, 44: 221-227. DOI: 10.1055/s-0031-1299681
    [15]
    Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort[J]. Lancet Diabetes Endocrinol, 2017, 5: 689-699. DOI: 10.1016/S2213-8587(17)30135-3
    • Related Articles

  • Related Articles

    [1]Professional Panel on Injection Aesthetics, National Quality Control Center for Plastic and Aesthetic Surgery. Consensus of Chinese Experts on Neck Injection Aesthetics (2024 Edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(6): 1289-1300. DOI: 10.12290/xhyxzz.2024-0617
    [2]ZHU Di, LUO Xufei, WANG Zijun, SHI Qianling, LI Haodong, WANG Ye, CHEN Yaolong. The Differences and Connections Among Expert Evidence, Expert Opinion and Expert Consensus in the Development of Guidelines[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 936-941. DOI: 10.12290/xhyxzz.2024-0542
    [3]YAN Xinchun, HUO Li. Evaluation of Von Hippel-Lindau Syndrome Through Novel Small Molecular Tracer 68Ga-NY104 PET/CT Imaging[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(4): 911-915. DOI: 10.12290/xhyxzz.2024-0216
    [4]National Center for Quality Assurance of Anesthesia. 2023 Chinese Expert Consensus Statement for Prevention and Management of Perioperative Hypothermia[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(4): 734-743. DOI: 10.12290/xhyxzz.2023-0266
    [5]The Subspecialty Group of Immunology, the Society of Pediatrics, Chinese Medical Association, Chinese Alliance of Pediatric Rheumatic and Immunologic Diseases, Alliance of Rheumatic and Immunologic Diseases, National Clinical Research Center for Child Health and Disorders. Chinese Expert Consensus on Juvenile Idiopathic Arthritis-associated Uveitis (2023)[J]. Medical Journal of Peking Union Medical College Hospital, 2023, 14(2): 247-256. DOI: 10.12290/xhyxzz.2023-0090
    [6]Multi-disciplinary Team for Rare Diseases, Peking Union Medical College Hospital National Rare Diseases Committee. Expert Consensus on Clobazam in the Treatment of Refractory Epilepsy (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(5): 768-782. DOI: 10.12290/xhyxzz.2022-0421
    [7]Chinese Society of Nuclear Medicine, Chinese Society of Molecular Imaging in Chinese Biophysical Society. Expert Consensus on Clinical Application of Integrin RGD Receptor Imaging (2022)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 227-234. DOI: 10.12290/xhyxzz.2022-0089
    [8]YU Jiren, WANG E, WANG Difen, CANG Jing, FENG Yi, ZHANG Xijing, YANG Yi, YANG Yunmei, WU Shuijing, WANG Weijian, DU Bin, SHANG You, LIN Ru, CHENG Baoli, XIE Guohao, FANG Xiangming. Expert Consensus on Perioperative Management of Elderly Septic Patients (2021)[J]. Medical Journal of Peking Union Medical College Hospital, 2021, 12(4): 481-489. DOI: 10.12290/xhyxzz.2021-0312
    [9]Chinese Committee on Antimicrobial Susceptibility Testing, European Committee on Antimicrobial Susceptibility Testing, European Society of Clinical Microbiology and Infectious Diseases, Expert Committee on Infectious Diseases, China Medical Education Association, YANG Qi-wen, MA Xiao-ling, HU Fu-pin, ZHANG Jing, SUN Tong-wen, CHEN Bai-yi, XU Ying-chun, LIU You-ning. Expert Consensus on Polymyxin Antimicrobial Susceptibility Testing and Clinical Interpretation[J]. Medical Journal of Peking Union Medical College Hospital, 2020, 11(5): 559-570. DOI: 10.3969/j.issn.1674-9081.2020.05.011
    [10]Yao-long CHEN, Xu-fei LUO, Ji-yao WANG, Xiao-qing LIU, Hong-cai SHANG, Ke-hu YANG. How to Distinguish between Clinical Practice Guidelines and Expert Consensus[J]. Medical Journal of Peking Union Medical College Hospital, 2019, 10(4): 403-408. DOI: 10.3969/j.issn.1674-9081.2019.04.018

  • Cited by

    Periodical cited type(7)

    1. 何新仪，申航，宋颖，张相双，何文雯，冯正平，胡金波，杨淑敏，李启富. ~(68)Ga-Pentixafor PET/CT辅助诊断双侧醛固酮瘤1例. 中华内科杂志. 2025(02): 173-177 .
    2. 叶玲彤，邱平，郭清华，吕朝晖. 基于1 mg地塞米松抑制联合ACTH兴奋试验的原发性醛固酮增多症分型诊断研究进展. 中华医学杂志. 2025(07): 564-568 .
    3. 张娜，谢阳，陈跃. ~(68)Ga-Pentixafor PET/CT在原发性醛固酮增多症分型中的临床价值. 中华核医学与分子影像杂志. 2025(03): 185-188 .
    4. 徐浩，陈忠. 原发性醛固酮增多症外科治疗的争议、挑战与展望. 现代泌尿生殖肿瘤杂志. 2024(01): 1-4 .
    5. 余振球，李治菁. 原发性醛固酮增多症治疗规范. 中国乡村医药. 2024(19): 4-9 .
    6. 兰玲，周美岑，霍丽丽，杨小兵，邓微，罗勇. 特殊原发性醛固酮增多症基于肾上腺静脉采血技术结果实施手术的结局观察. 中华医学杂志. 2024(40): 3775-3779 .
    7. 张洁，王刚刚，赵进委，叶新华，唐蛰雨，贾中芝，杨其贤，王凯，杜云峰. 肾上腺静脉采血患者的围术期管理. 手术电子杂志. 2023(04): 44-48 .

    Other cited types(2)

Catalog

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (1272) PDF downloads (489) Cited by(9)
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return
    x Close Forever Close